A study for a 78 year old man who takes Lipitor, Dopar, Micardis, Spironolactone - from FDA reports


9 males aged 78 (±5) who take the same drugs are studied. This is a personalized study for a 78 year old male patient who has Parkinsonism, High Blood Pressure, Atherosclerosis. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 03, 2017

9 males aged 78 (±5) who take Lipitor, Dopar, Micardis, Spironolactone are studied.

Number of reports submitted per year:

Lipitor, Dopar, Micardis, Spironolactone for a 78-year old man.

Information of the patient in this study:

  • Age: 78
  • Gender: male
  • Conditions: Parkinsonism, High Blood Pressure, Atherosclerosis
  • Drugs taken:
    • Lipitor (atorvastatin calcium)
    • Dopar (levodopa)
    • Micardis (telmisartan)
    • Spironolactone (spironolactone)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
1 - 6 months:
  • cardiac tamponade
  • pericardial haemorrhage
6 - 12 months:
1 - 2 years:
  • cardiac tamponade
  • pericardial haemorrhage
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  • thrombocytopenia
  • fatigue
  • alanine aminotransferase increased
  • pulmonary oedema
  • hepatic function abnormal
  • renal failure acute
  • pericardial haemorrhage
  • low cardiac output syndrome
  • multi-organ failure
  • cardiac tamponade

Top conditions involved for these people *:

  • Cardiac Failure (4 people, 44.44%)
  • Stroke (2 people, 22.22%)
  • Myocardial Ischaemia (2 people, 22.22%)
  • Gastritis (2 people, 22.22%)
  • Arrhythmias (2 people, 22.22%)

Top co-used drugs for these people *:

  • Lasix (6 people, 66.67%)
  • Norvasc (3 people, 33.33%)
  • Xarelto (2 people, 22.22%)
  • Tambocor (2 people, 22.22%)
  • Nesina (2 people, 22.22%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Spironolactone, Lipitor, Dopar, Atherosclerosis, Micardis, Parkinsonism, High blood pressure

You may be interested in these reviews

More reviews for: Spironolactone, Lipitor, Dopar, Atherosclerosis, Micardis, Parkinsonism, High blood pressure